ZOETIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.6 USD | +2.76% |
|
-2.26% | -24.22% |
| Apr. 23 | Barclays Adjusts Zoetis' Price Target to $230 From $260, Keeps Overweight Rating | MT |
| Apr. 22 | Jefferies Lowers Zoetis Price Target to $200 from $220 | MT |
Chart calendar Zoetis Inc.
6706514f.ZyL7vkykgsKqTdfWhE0Dut1KvtUmj6mSnMiIpVCj-Ac.BHDJjQvq0o3nF7aT_T9h1IklipBQu_re_p3C6x3iqzcLS6LoKpW2iOw0hg~8dfa94b1f142972cdaba99d6b9814025
Upcoming events on Zoetis Inc.
Past events on Zoetis Inc.
| 2024-03-14 08:30 am | Barclays Global Healthcare Conference |
| 2024-02-29 11:40 am | Bank of America Securities Animal Health Summit |
| 2024-02-13 08:30 am | Q4 2023 Earnings Call |
| 2024-02-13 07:00 am | Q4 2023 Earnings Release |
| 2024-01-08 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-28 01:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 07:00 am | Q3 2023 Earnings Release |
| 2023-09-12 12:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 07:00 am | Q2 2023 Earnings Release |
| 2023-05-31 03:35 pm | Stifel Jaws & Paws Conference |
| 2023-05-25 09:00 am | Investor Day |
| 2023-05-18 08:00 am | Annual General Meeting |
| 2023-05-04 08:30 am | Q1 2023 Earnings Call |
| 2023-05-04 07:00 am | Q1 2023 Earnings Release |
| 2023-03-06 11:10 am | Cowen Health Care Conference |
| 2023-03-02 12:30 pm | Bank of America Health Summit |
| 2023-02-14 08:30 am | FY 2022 Earnings Call |
| 2023-02-14 07:00 am | FY 2022 Earnings Release |
Past dividends on Zoetis Inc.
| 2024-04-17 | Quarterly 0.432 USD |
| 2024-01-17 | Quarterly 0.432 USD |
| 2023-10-30 | Quarterly 0.375 USD |
| 2023-07-19 | Quarterly 0.375 USD |
| 2023-04-19 | Quarterly 0.375 USD |
| 2023-01-18 | Quarterly 0.375 USD |
| 2022-10-30 | Quarterly 0.325 USD |
| 2022-07-19 | Quarterly 0.325 USD |
| 2022-04-19 | Quarterly 0.325 USD |
| 2022-01-18 | Quarterly 0.325 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 260 6 231 0.46% | 6 675 6 602 1.1% | 7 776 7 747 0.37% | 8 080 8 043 0.46% | 8 544 8 523 0.25% | 9 169 |
|
EBITDA Million USD | Released Forecast Spread | 2 743 2 615 4.9% | 2 940 2 806 4.76% | 3 434 3 336 2.94% | 3 561 3 439 3.53% | 3 722 3 678 1.18% | 4 009 |
|
EBIT Million USD | Released Forecast Spread | 2 331 2 336 -0.23% | 2 499 2 516 -0.66% | 2 986 2 973 0.45% | 3 096 3 089 0.23% | 3 231 3 288 -1.73% | 3 524 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 801 1 822 -1.16% | 1 996 2 047 -2.5% | 2 488 2 490 -0.08% | 2 656 2 634 0.84% | 2 936 2 962 -0.87% | 3 228 |
|
Net income Million USD | Released Forecast Spread | 1 500 1 466 2.35% | 1 638 1 645 -0.42% | 2 037 2 020 0.86% | 2 114 2 123 -0.42% | 2 344 2 382 -1.61% | 2 533 |
|
EPS USD | Released Forecast Spread | 3,11 3,04 2.18% | 3,42 3,40 0.72% | 4,27 4,25 0.41% | 4,49 4,56 -1.63% | 5,07 5,19 -2.35% | 5,47 |
| Announcement Date | 13/02/20 | 16/02/21 | 15/02/22 | 14/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 967 1 932 1.81% | 1 986 1 977 0.43% | 2 052 2 026 1.3% | 2 002 2 082 -3.84% | 2 040 2 006 1.72% | 2 000 2 015 -0.76% | 2 180 2 157 1.05% | 2 151 2 174 -1.07% | 2 213 2 192 0.97% | 2 156 | 2 329 | 2 312 | 2 368 | 2 278 |
|
EBITDA Million USD | Released Forecast Spread | 756 705 7.22% | 946 794 19.12% | 887 827 7.29% | 879 859 2.29% | 849 820 3.57% | 857 | 898 | 977 | 970 | 962 | ||||
|
EBIT Million USD | Released Forecast Spread | 639 620 3.12% | 832 773 7.63% | 770 782 -1.57% | 764 786 -2.84% | 730 723 0.99% | 770 778 -1.08% | 877 820 6.94% | 839 839 -0.06% | 745 822 -9.38% | 835 | 928 | 916 | 864 | 895 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 650 | 768 | 849 | 846 | 840 | |||||||||
|
Net income Million USD | Released Forecast Spread | 414 413 0.12% | 595 529 12.37% | 529 519 1.97% | 529 523 1.13% | 461 494 -6.61% | 552 553 -0.18% | 671 583 15.18% | 596 587 1.56% | 525 559 -6.1% | 591 | 689 | 657 | 634 | |
|
EPS USD | Released Forecast Spread | 0,87 0,88 -0.76% | 1,26 1,14 11.01% | 1,12 1,13 -0.88% | 1,13 1,11 1.8% | 0,99 1,04 -4.58% | 1,19 1,18 0.63% | 1,45 1,25 16.23% | 1,29 1,26 2.18% | 1,14 1,24 -7.69% | 1,28 | 1,45 | 1,42 | 1,34 | 1,34 |
| Announcement Date | 15/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 14/02/23 | 04/05/23 | 08/08/23 | 02/11/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for Zoetis Inc.
| 2024-04-16 11:45 am | VIRBAC: Q1 2024 Sales and Revenue Release |
| 2024-04-15 | WUHAN KEQIAN BIOLOGY CO.,LTD: Q1 2024 Earnings Release (Projected) |
| 2024-04-09 | CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-01 | WUHAN KEQIAN BIOLOGY CO.,LTD: Q4 2023 Earnings Release |
| 2024-03-29 | TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.: Q4 2023 Earnings Release |
| 2024-03-28 | BLUESTAR ADISSEO COMPANY: Q4 2023 Earnings Release |
| 2024-03-20 12:45 pm | VETOQUINOL SA: Q4 2023 Earnings Release |
| 2024-03-19 12:45 pm | VIRBAC: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | PETIQ, INC.: Q4 2023 Earnings Release |
| 2024-02-26 06:27 am | ELANCO ANIMAL HEALTH INCORPORATED: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZTS Stock
- Calendar Zoetis Inc.
